South America Virus-like Particles Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Hepatitis, Cancer/HPV, and Gaucher disease), Source (Yeast, Insect Cell, Plant, and Others), and Application (Vaccines and Therapeutics)

No. of Pages: 104    |    Report Code: TIPRE00026835    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
South America Virus-like Particles Market

1.          Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        South America Virus-like Particles Market – By Product Type

1.3.2        South America Virus-like Particles Market – By Source

1.3.3        South America Virus-like Particles Market – By Application

1.3.4        South America Virus-like Particles Market – By Country

2.           South America Virus-like Particles Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           South America Virus-like Particles Market Landscape

4.1         Overview

4.2         PEST Analysis

4.3         Experts Opinion

5.           South America Virus-like Particles Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Up-raising Prevalence of Infectious Viral Diseases

5.1.2        Surging Role of Virus-Like Particles in Therapeutic Developments and Studies

5.2         Market Restraints

5.2.1        Availableness of Alternative Technologies for Viral Vaccine Production

5.3         Market Opportunities

5.3.1        Scaling Potential Applications in Therapeutics and Diagnostics

5.4         Future Trends

5.4.1        Consistent Demand for Innovative and Effective Products

5.5         Impact Analysis

6.           South America Virus-like Particles Market Analysis

6.1         South America Virus-like Particles Market Revenue Forecast and Analysis

7.           South America Virus-like Particles Market Analysis – by Product Type

7.1         Overview

7.2         South America Virus-like Particles Market, by Product Type, 2021 & 2028 (%)

7.3         Hepatitis

7.3.1        Overview

7.3.2        Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

7.4         Cancer/ Human Papillomavirus (HPV)

7.4.1        Overview

7.4.2        Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

7.5         Gaucher Disease

7.5.1        Overview

7.5.2        Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.           South America Virus-like Particles Market Analysis – By Source

8.1         Overview

8.2         South America Virus-like Particles Market Share, by Source, 2021 & 2028 (%)

8.3         Yeast

8.3.1        Overview

8.3.2        Yeast: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.4         Plant

8.4.1        Overview

8.4.2        Plant: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.5         Insect Cell

8.5.1        Overview

8.5.2        Insect Cell: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.6         Others

8.6.1        Overview

8.6.2        Others: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

9.           South America Virus-like Particles Market Analysis – By Application

9.1         Overview

9.2         South America Virus-like Particles Market Share, by Application, 2021 & 2028 (%)

9.3         Vaccines

9.3.1        Overview

9.3.2        Vaccine: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

9.4         Therapeutics

9.4.1        Overview

9.4.2        Therapeutics: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.        South America Virus-like Particles Market – Country Analysis

10.1      Overview

10.1.1     South America Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)

10.1.1.1       Brazil: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

10.1.1.1.1       Overview

10.1.1.1.2       Brazil: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

10.1.1.1.3       Brazil: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.4       Brazil Virus-like Particles Market, by Source - Revenue and Forecasts To 2028 (US$ Million)

10.1.1.1.5       Brazil Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.2       Argentina Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

10.1.1.2.1       Overview

10.1.1.2.2       Argentina Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

10.1.1.2.3       Argentina: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.4       Argentina: Virus-like Particles Market, by Source - Revenue and Forecasts To 2028 (US$ Million)

10.1.1.2.5       Argentina Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.3       Rest of South America: Virus-like Particles Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1       Overview

10.1.1.3.2       Rest of South America: Virus-like Particles Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3       Rest of South America: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.4       Rest of South America: Virus-like Particles Market, by Source - Revenue and Forecasts To 2028 (US$ Million)

10.1.1.3.5       Rest of South America Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

11.        Impact Of COVID-19 Pandemic on South America Virus-like Particles Market

11.1      Impact Assessment of COVID-19 Pandemic

12.        South America Virus-like Particles Market–Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        Company Profiles

13.1      Merck & Co., Inc.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      GlaxoSmithKline plc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Pfizer Inc.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Sanofi

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Serum Institute of India Pvt. Ltd.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      BHARAT BIOTECH

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      LG Chem

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             South America Virus-like Particles Market, Revenue and Forecast to 2028 (US$ Million)

Table 2.             Brazil: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)

Table 3.             Brazil Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 4.             Brazil Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 5.             Argentina: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)

Table 6.             Argentina: Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 7.             Argentina Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 8.             Rest of South America: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)

Table 9.             Rest of South America: Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 10.          Rest of South America Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 11.          Organic Developments Done by Companies

Table 12.          Inorganic Developments Done by Companies

Table 13.          Glossary of Terms: Virus-like Particles Market

 


LIST OF FIGURES

Figure 1.           South America Virus-like particles Market Segmentation

Figure 2.           South America Virus-like particles Market Segmentation, By Country

Figure 3.           South America Virus-like Particles Market Overview

Figure 4.           Hepatitis Held the Largest Share of the Product Type Segment in South America Virus-like particles Market

Figure 5.           Brazil to Show Significant Growth during Forecast Period

Figure 6.           South America Virus-like Particles Market, Industry Landscape

Figure 7.           South America PEST Analysis

Figure 8.           South America Virus-like Particles Market: Impact Analysis of Drivers and Restraints

Figure 9.           South America Virus-like Particles Market– Revenue Forecast and Analysis to 2028

Figure 10.        South America Virus-like Particles Market, by Product Type, 2021 & 2028 (%)

Figure 11.        Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 14.        South America Virus-like Particles Market Share, by Source, 2021 & 2028 (%)

Figure 15.        Yeast: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16.        Plant: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17.        Insect Cell: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18.        Others: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19.        South America Virus-like Particles Market Share, by Application, 2021 & 2028 (%)

Figure 20.        Vaccine: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21.        Therapeutics: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22.        South America Virus-like Particles Market Revenue Overview, by Country, 2021 (US$ Million)

Figure 23.        South America Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)

Figure 24.        Brazil: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25.        Argentina Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26.        Rest of South America: Virus-like Particles Market– Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Impact Of COVID-19 Pandemic in South America Country Markets

The List of Companies - South America Virus-like Particles Market

  1. Merck & Co., Inc.                                                       
  2. GlaxoSmithKline plc.                                                
  3. Pfizer Inc.                                                                    
  4. Sanofi                                                                         
  5. Serum Institute of India Pvt. Ltd.                           
  6. BHARAT BIOTECH                                                      
  7. LG Chem